These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20333904)

  • 1. Hypertension and chronic kidney disease: the role of lifestyle modification and medication management.
    Eskridge MS
    Nephrol Nurs J; 2010; 37(1):55-60, 99. PubMed ID: 20333904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
    Murphy F; Jenkins K; Chamney M; McCann M; Sedgewick J
    J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing chronic kidney disease care: new imperatives for recognition and intervention.
    Szromba C; Thies MA; Ossman SS
    Nephrol Nurs J; 2002 Dec; 29(6):547-59; quiz 560-1. PubMed ID: 12596604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension awareness, treatment, and control in chronic kidney disease.
    Sarafidis PA; Li S; Chen SC; Collins AJ; Brown WW; Klag MJ; Bakris GL
    Am J Med; 2008 Apr; 121(4):332-40. PubMed ID: 18374693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling hypertension from a public health perspective.
    Chiong JR
    Int J Cardiol; 2008 Jul; 127(2):151-6. PubMed ID: 18191246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular risk management through nurse-led self-management programs.
    Sol BG; van der Bijl JJ; Banga JD; Visseren FL
    J Vasc Nurs; 2005 Mar; 23(1):20-4. PubMed ID: 15741961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
    Bakris GL; Ritz E;
    J Hypertens; 2009 Mar; 27(3):666-9. PubMed ID: 19262237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertension in Italian nephrology out-patient clinics: the THIN Study.
    Russo D; Andreucci M; De Blasio A; Frattolillo P; Andreucci VE
    Semin Nephrol; 2005 Nov; 25(6):431-4. PubMed ID: 16298268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the stages of chronic kidney disease.
    Castner D
    Nursing; 2010 May; 40(5):24-31; quiz 31-2. PubMed ID: 20386393
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a self-management package for people with diabetes at risk of chronic kidney disease (CKD).
    Thomas N; Bryar R; Makanjuola D
    J Ren Care; 2008 Sep; 34(3):151-8. PubMed ID: 18786082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study.
    De Nicola L; Minutolo R; Zamboli P; Cestaro R; Marzano L; Giannattasio P; Cristofano C; Chimienti S; Savica V; Bellinghieri G; Rapisarda F; Fatuzzo P; Conte G;
    Semin Nephrol; 2005 Nov; 25(6):425-30. PubMed ID: 16298267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and managing factors that interfere with or worsen blood pressure control.
    Basile JN; Bloch MJ
    Postgrad Med; 2010 Mar; 122(2):35-48. PubMed ID: 20203454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.